Commonwealth Equity Services
CRDF icon

Commonwealth Equity Services’s Cardiff Oncology CRDF Stock Holding History

Commonwealth Equity Services’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-28,465
Closed -$59K – 4319
2025
Q3 		$59K Buy
28,465
+1,200
+4% +$3.32K ﹤0.01% 4150
2025
Q2 		$86K Buy
27,265
+6,956
+34% +$21.2K ﹤0.01% 4090
2025
Q1 		$64K Buy
20,309
+2,654
+15% +$10.5K ﹤0.01% 4041
2024
Q4 		$77K Hold
17,655
– – ﹤0.01% 3941
2024
Q3 		$47K Buy
+17,655
New +$41.7K ﹤0.01% 3941

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Commonwealth Equity Services's CRDF Position: Q4 2025 in Review

Commonwealth Equity Services sold out of Cardiff Oncology (CRDF) in Q4 2025, closing a stake of 28,465 shares — an estimated $59K sold.

Commonwealth Equity Services first reported a position in CRDF in Q3 2024 and held it in 5 quarters. The position peaked at $86K in Q2 2025. 110 funds tracked by Wall St. Rank hold CRDF as of Q4 2025.

  • Commonwealth Equity Services reported no remaining Cardiff Oncology position as of Q4 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 28,465 Cardiff Oncology shares in Q4 2025, an estimated $59K.
  • Commonwealth Equity Services first reported a position in Cardiff Oncology in Q3 2024 and held it in 5 quarters.
  • Commonwealth Equity Services's Cardiff Oncology position peaked at $86K in Q2 2025.
  • 110 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2025.

Based on Commonwealth Equity Services's 13F filing for Q4 2025, filed 12 Feb 2026.